| LGSCX | VSCIX | LGSCX / VSCIX | |
| Total Expense Ratio | 1.30 | 0.04 | 3,250% |
| Annual Report Gross Expense Ratio | 1.62 | 0.04 | 4,050% |
| Fund Existence | 23 years | 28 years | - |
| Gain YTD | 23.990 | 11.042 | 217% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 133M | 163B | 0% |
| Annual Yield % from dividends | 0.31 | 1.33 | 23% |
| Returns for 1 year | 11.62 | 4.24 | 274% |
| Returns for 3 years | 42.49 | 41.65 | 102% |
| Returns for 5 years | 24.55 | 42.77 | 57% |
| Returns for 10 years | 37.86 | 153.47 | 25% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IVGAX | 19.82 | 0.17 | +0.87% |
| VY® Invesco Growth and Income A | |||
| THOFX | 47.60 | 0.14 | +0.29% |
| Thornburg Global Opportunities R5 | |||
| PHPSX | 28.88 | -0.14 | -0.48% |
| ProFunds Pharmaceuticals UltraSector Svc | |||
| JMEEX | 65.35 | -2.99 | -4.38% |
| JPMorgan Mid Cap Equity R5 | |||
| GCSUX | 30.58 | -2.41 | -7.31% |
| Goldman Sachs Small Cap Eq Insghts R6 | |||